Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muzaffar H Qazilbash

Showing results (71-80 of 188) with videos related to

Pageof 19
Sort By:
British Journal of Haematology|March 22, 2021
Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide-based maintenance therapyChutima Kunacheewa, Lei Feng, Elisabet E Manasanch, et al.
Leukemia & Lymphoma|December 3, 2011
Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer CenterPaolo Anderlini, Rima Saliba, Sandra Acholonu, et al.
Leukemia & Lymphoma|July 24, 2018
High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomesBei Hu, Peter Thall, Denái R Milton, et al.
British Journal of Haematology|June 20, 2008
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantationAmin M Alousi, Rima M Saliba, Grace-Julia Okoroji, et al.
Transplantation and Cellular Therapy|September 24, 2023
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative ConditioningJacinth Joseph, Samer A Srour, Denái R Milton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2018
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell TransplantationAimaz Afrough, Rima M Saliba, Amir Hamdi, et al.
Blood|June 4, 2020
Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALLNeeraj Saini, David Marin, Celina Ledesma, et al.
Leukemia & Lymphoma|July 26, 2011
Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myelomaQaiser Bashir, Nina Shah, Simrit Parmar, et al.
The American Journal of Surgical Pathology|August 24, 2017
Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host DiseaseJin S Im, Susan C Abraham, Rima M Saliba, et al.
Bone Marrow Transplantation|November 18, 2018
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugsLohith Gowda, Mithun Shah, Ifra Badar, et al.
Pageof 19

Showing results (71-80 of 188) with videos related to

Sort By:
Pageof 19
British Journal of Haematology|March 22, 2021
Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide-based maintenance therapyChutima Kunacheewa, Lei Feng, Elisabet E Manasanch, et al.
Leukemia & Lymphoma|December 3, 2011
Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer CenterPaolo Anderlini, Rima Saliba, Sandra Acholonu, et al.
Leukemia & Lymphoma|July 24, 2018
High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomesBei Hu, Peter Thall, Denái R Milton, et al.
British Journal of Haematology|June 20, 2008
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantationAmin M Alousi, Rima M Saliba, Grace-Julia Okoroji, et al.
Transplantation and Cellular Therapy|September 24, 2023
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative ConditioningJacinth Joseph, Samer A Srour, Denái R Milton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2018
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell TransplantationAimaz Afrough, Rima M Saliba, Amir Hamdi, et al.
Blood|June 4, 2020
Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALLNeeraj Saini, David Marin, Celina Ledesma, et al.
Leukemia & Lymphoma|July 26, 2011
Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myelomaQaiser Bashir, Nina Shah, Simrit Parmar, et al.
The American Journal of Surgical Pathology|August 24, 2017
Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host DiseaseJin S Im, Susan C Abraham, Rima M Saliba, et al.
Bone Marrow Transplantation|November 18, 2018
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugsLohith Gowda, Mithun Shah, Ifra Badar, et al.
Pageof 19